semaglutide beyond use date expiration glp 1 expiration date Semaglutide Safety Alerts, Recalls & Warnings Expired Semaglutide: Risks & Prevention

Controlled substance weight loss drugs include the following: Adipex-P (phentermine): Listed as a Schedule IV drug by the DEA, phentermine remains a commonly prescribed weight loss treatment, but it is only approved for three months of use and has contraindications to its use that center around its abuse potential and cardiovascular risk

The relationship between gastric sleeve surgery and blood pressure is not limited to the immediate post-operative period

Fast Risers: AstraZeneca, Lilly, and Novo Nordisk The fastest-growing companies in the top 10 were AstraZeneca, with all of its key therapy areas seeing sales rise by double-digit percentages, and Eli Lilly, driven by its tirzepatide GIP/GLP-1 receptor agonist products for diabetes and obesity, Mounjaro and Zepbound

While results can vary, many clients start to notice a reduction in appetite and some weight loss within the first few weeks of starting treatment

Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review

AOM tirzepatide prescription rates increased by an average of 0.06 percentage points a month from January 2024 to June 2025 but grew only by 0.03 percentage points between June and July